Bioorganic and Medicinal Chemistry Letters p. 2557 - 2561 (2000)
Update date:2022-08-04
Topics:
Boyd, Helen F.
Fell, Stephen C. M.
Flynn, Sean T.
Hickey, Deirdre M. B.
Ife, Robert J.
Leach, Colin A.
Macphee, Colin H.
Milliner, Kevin J.
Moores, Kitty E.
Pinto, Ivan L.
Porter, Rod A.
Rawlings
Smith, Stephen A.
Stansfield, Ian G.
Tew, David G.
Theobald, Colin J.
Whittaker, Caroline M.
From two related series of 2-(alkylthio)-pyrimidones, a novel series of 1-((amidolinked)-alkyl)-pyrimidones has been designed as nanomolar inhibitors of human lipoprotein-associated phopholipase A2. These compounds show greatly enhanced activity in isolated plasma. Selected derivatives such as compounds 51 and 52 are orally active with a good duration of action. (C) 2000 Elsevier Science Ltd.
View MoreWUHU HUAHAI BIOLOGY ENGINEERING CO LTD
Contact:+86-553-3836920
Address:7/F NO.82 LAODONG ROAD WUHU CHINA
Airsea(Taizhou) Pharmaceutical Limited(expird)
Contact:+86-576-88057622
Address:Dubei, Duqiao, Linhai, Taizhou, Zhejiang, China Zip: 317016
Shanghai Kefu Chemical Co.,Ltd.
Contact:+86-21-34616196
Address:Room601-602, Xuhui Business Building, No.168, Yude Road, Shanghai
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
Contact:13357117572
Address:No.149 Shiji dadao Road.
Doi:10.1002/ejoc.201001735
(2011)Doi:10.1039/b008878l
(2001)Doi:10.1002/ejoc.201200064
(2012)Doi:10.1016/S0022-328X(98)01074-2
(1999)Doi:10.1016/S0040-4039(97)01733-4
(1997)Doi:10.1080/07328309908543998
(1999)